Sitemap |  Press & Events |  Publications |  Links |     Search :
ONALTA KITS
Edotreotide acetate lyophilized kits
DOTA-Tyr3-Octreotide (Edotreotide acetate)0.072-0.088 mg
Gentisic acid14.4-17.6 mg
Non-toxic Inositol36.0-44.0 mg
Non-toxic Ascorbic Acid64.0-78.2 mg
A cold GMP kit, pharmaceutical grade and ready to be labeled with 90Y, according to a defined labeling protocol, for the treatment of metastatic carcinoid and pancreatic neuroendocrine tumors in patients whose symptoms are not controlled by conventional therapy.
For more information please contact info@biomedica.gr.

GMP DOTATOC
Octreotide Acetate
DOTA-(Tyr3)-Octreotide Acetate
C65H92N14O18S2
DOTA-Conjugated somatostatin analog for labeling with radiometals like 68Ga,111In,90Y and 177Lu. Potentially useful for receptor- mediated tumor imaging.
For more information please contact info@biomedica.gr.
 

Biomedica Life Sciences S.A. is a privately held, vertically integrated Specialty Pharmaceutical Company, headquartered in Greece (Athens), focused on the emerging field of Nuclear Medicine and more specifically in the Molecular Imaging and Targeted Therapies. The Company since its establishment in 1987 is dynamically active in the Health Sector and has established a leading position in covering the market needs of the health industry in diagnostic and therapeutic products, specific medical devices and services. Biomedica Life Sciences S.A. has launched and marketed a unique portfolio of innovative radiopharmaceutical products in Greece.
The Company’s core activity, utilizing the expertise that has been developed through the past years, spans over the following fields:

Development and commercialization of innovative radiopharmaceutical products and services through internal R&D efforts
Sourcing late stage radiopharmaceutical diagnostics and therapies for development and commercialization in Europe, Turkey and the Middle East  
Investing in research partnerships with academic institutions and research centers
 

Biomedica Life Sciences S.A. in order to optimize its efficiency in exploiting the results of the R&D activities, has established two Spin-off Companies in which is the controlling shareholder.
The companies are :
 

Biomedica Life Sciences S.A
2 Tenedou Street, Vrilissia
15235 Athens, Greece
T:+30 210 6899801
F:+30 210 6899809
E:info@biomedica.gr
    Legal | Privacy Policy |© biomedica 2009